EpiPen pricing, and a New York Times article on that issue, are the topic of my column. Please check the full column out at Newsmax (here) and Reason (here).
EpiPen Underpriced Despite Times Complaint
https://www.futureofcapitalism.com/2017/06/epipen-underpriced-despite-times-complaint
by Editor | Related Topics: Health Care receive the latest by email: subscribe to the free futureofcapitalism.com mailing list
